Maria Zannes
President, CEO at bioAffinity Technologies Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: bioAffinity Technologies Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
bioAffinity Technologies Inc. July 25, 202598.5%
-
bioAffinity Technologies Inc. June 4, 202499.6%
-
bioAffinity Technologies Inc. June 7, 202399.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 10, 2025 | bioAffinity Technologies Inc. | Grant or award | +37,037 | — | — |
| Jul 1, 2024 | bioAffinity Technologies Inc. | Grant or award | +33,784 | — | — |
| Jun 12, 2024 | bioAffinity Technologies Inc. | Grant or award | +8,296 | — | — |
| Apr 8, 2024 | bioAffinity Technologies Inc. | Option exercise | +64,848 | $1.16 | $75,224 |
| Apr 8, 2024 | bioAffinity Technologies Inc. | Shares withheld for tax | −28,264 | $2.65 | $74,900 |
| Jan 31, 2024 | bioAffinity Technologies Inc. | Grant or award | +23,885 | — | — |
| Jan 1, 2024 | bioAffinity Technologies Inc. | Grant or award | +12,668 | $1.48 | $18,749 |
| Oct 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +11,867 | $1.58 | $18,750 |
| Jul 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +10,245 | $1.83 | $18,748 |
| Jun 6, 2023 | bioAffinity Technologies Inc. | Grant or award | +26,178 | $1.91 | $50,000 |
| Apr 15, 2023 | bioAffinity Technologies Inc. | Grant or award | +9,920 | $1.89 | $18,749 |
| Jan 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +8,227 | $2.28 | $18,758 |
Questions about Maria Zannes
What boards is Maria Zannes on?
Maria Zannes sits on the board of bioAffinity Technologies Inc.
What company is Maria Zannes the CEO of?
Maria Zannes is President, CEO of bioAffinity Technologies Inc.
How long has Maria Zannes served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.